| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0022-3476(03)00279-8 |
| P698 | PubMed publication ID | 12915830 |
| P2093 | author name string | Abhay Vats | |
| Demetrius Ellis | |||
| Mary Jo Grosso | |||
| Michael L Moritz | |||
| Janine E Janosky | |||
| Susanne Reitz | |||
| P2860 | cites work | Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes | Q28188162 |
| Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat | Q28360398 | ||
| Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy | Q29615215 | ||
| Renal protection and antihypertensive drugs: current status | Q33649627 | ||
| Practical considerations of the pharmacology of angiotensin receptor blockers | Q33650699 | ||
| Comparative safety and tolerability of angiotensin II receptor antagonists | Q33703340 | ||
| Angiotensin II receptor antagonists | Q33851581 | ||
| Renoprotective benefits of RAS inhibition: from ACEI to angiotensin II antagonists | Q33904463 | ||
| Use of single voided urine samples to estimate quantitative proteinuria | Q34662083 | ||
| Albumin Excretion as a Measure of Glomerular Dysfunction in Children | Q35148686 | ||
| Clinical pharmacology of ACE inhibition | Q38678685 | ||
| Specific inhibition of the renin-angiotensin system: A key to understanding blood pressure regulation | Q39902030 | ||
| The role of proteinuria in the progression of chronic renal failure | Q40999024 | ||
| Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system? | Q42285869 | ||
| The natural history of immunoglobulin a nephropathy among patients with hematuria and minimal proteinuria | Q43593875 | ||
| Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy. | Q43657220 | ||
| Renal involvement in Henoch-Schönlein purpura: a multivariate analysis of prognostic factors | Q43662668 | ||
| The Effects of Dietary Protein Restriction and Blood-Pressure Control on the Progression of Chronic Renal Disease | Q56867091 | ||
| Dosing angiotensin II blockers—beyond blood pressure | Q56987365 | ||
| Pathophysiology of Progressive Nephropathies | Q57703963 | ||
| Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy | Q57704237 | ||
| Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy | Q59489271 | ||
| Long-Term Beneficial Effects of Angiotensin-Converting Enzyme Inhibition in Patients With Nephrotic Proteinuria | Q61456193 | ||
| Influence of converting enzyme inhibition on glomerular filtration rate and proteinuria | Q61456207 | ||
| Antihypertensive Therapy with MK 4211 | Q62090301 | ||
| The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children, and adolescents | Q69035747 | ||
| Plasma angiotensins and blood pressure during converting enzyme inhibition | Q70182763 | ||
| The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group | Q70513402 | ||
| Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group | Q70989850 | ||
| Functional and biochemical analysis of angiotensin II-forming pathways in the human heart | Q73023637 | ||
| Antiproteinuric effect of Losartan in patients with chronic renal diseases | Q73060954 | ||
| Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE) | Q73164612 | ||
| ACE inhibitors and angiotensin II antagonists in renal transplantation: an analysis of safety and efficacy | Q73323291 | ||
| Effect of ACE inhibitors in diabetic and nondiabetic chronic renal disease: a systematic overview of randomized placebo-controlled trials | Q73598695 | ||
| Growth and renal function after steroid-free tacrolimus-based immunosuppression in children with renal transplants | Q74059783 | ||
| Control of severe proteinuria with losartan after renal transplantation | Q74649064 | ||
| Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy | Q77357891 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | losartan | Q410074 |
| P304 | page(s) | 89-97 | |
| P577 | publication date | 2003-07-01 | |
| P1433 | published in | The Journal of Pediatrics | Q7743611 |
| P1476 | title | Long-term antiproteinuric and renoprotective efficacy and safety of losartan in children with proteinuria | |
| P478 | volume | 143 |
| Q33404886 | Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome |
| Q61654118 | Antagonistas de los receptores de la angiotensina y protección frente al desarrollo de enfermedad renal |
| Q37152477 | Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study |
| Q42663516 | Candesartan cilexetil effectively reduces blood pressure in hypertensive children |
| Q31046838 | Candesartan cilexetil in children with hypertension or proteinuria: preliminary data. |
| Q36120049 | Chronic kidney disease in children: the global perspective |
| Q50210234 | Development of tandem mass spectrometry-based creatinine measurement using dried blood spot for newborn mass screening |
| Q38042582 | Educational paper: Progression in chronic kidney disease and prevention strategies |
| Q33395128 | Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy |
| Q46188142 | Effect of enalapril on glomerular filtration rate and proteinuria in children with chronic kidney disease: a randomized controlled trial |
| Q33516579 | Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents |
| Q38370762 | Evidence-based guidelines for the management of hypertension in children with chronic kidney disease |
| Q84978295 | Evidence-based practice guideline for the treatment of CKD |
| Q36985443 | Genetic testing in nephrotic syndrome--challenges and opportunities |
| Q37593672 | Hypertension in children and adolescents: an approach to management of complex hyper-tension in pediatric patients |
| Q40864037 | Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors |
| Q36025078 | Palatability of angiotensin II antagonists among nephropathic children. |
| Q33683988 | Randomized, double-blind, controlled study of losartan in children with proteinuria. |
| Q40602735 | Rapidly progressive aortic aneurysmal dilation in a child with systemic lupus erythematosus: too early too severe |
| Q49500608 | Steroid-resistant nephrotic syndrome: past and current perspectives |
| Q36510669 | Therapeutic strategies to slow chronic kidney disease progression |
Search more.